SENS Research Foundation
Overview
SENS Research Foundation is a 501(c)(3) non-profit organization that works to research, develop, and promote comprehensive regenerative medicine solutions for the diseases of aging. It funds research, conducts outreach and education, and provides funding and support to promising biotechnology startups to expedite the development of rejuvenation biotechnologies. The foundation's strategy is to apply the principles of regenerative medicine to repair the cellular and molecular damage that accumulates with age. It also spins out new companies from its research programs.
Portfolio Companies
2
Website
sens.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Repair Biotechnologies | Jun 2023 | Series A | Co-investor |
| Oisín Biotechnologies | Feb 2020 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SENS Research Foundation based?
SENS Research Foundation is headquartered in Mountain View, California, United States.
When was SENS Research Foundation founded?
Founding year information for SENS Research Foundation is not publicly available.
How many portfolio companies does SENS Research Foundation have?
SENS Research Foundation has 2 portfolio companies in Caplight's dataset.
What are some companies in SENS Research Foundation's portfolio?
Portfolio companies visible on Caplight include Repair Biotechnologies, Oisín Biotechnologies.
What was SENS Research Foundation's most recent investment shown here?
SENS Research Foundation's most recent investment in this portfolio sample was in Repair Biotechnologies in 2023.
What sectors does SENS Research Foundation focus on?
SENS Research Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does SENS Research Foundation focus on?
SENS Research Foundation typically invests at the Early stage.
What is SENS Research Foundation's AUM?
SENS Research Foundation's assets under management are estimated between $15.1M and $15.1M.